Summit Therapeutics Inc. (SMMT) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Summit Therapeutics Inc. (SMMT)
Last summit therapeutics inc. earnings: 6/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
summitplc.com/investors/investor-centre
Company Research
Source: Seeking Alpha
Dave Gancarz - Chief Business & Strategy Officer Allen Yang - Head of R&D Strategy Robert Duggan - Co-CEO & Executive Chairman Conference Call Participants Cory Kasimov - Evercore ISI Institutional Equities, Research Division Presentation Cory Kasimov Evercore ISI Institutional Equities, Research Division All right. Good afternoon, everyone. My name is Cory Kasimov, one of the senior biotech analysts here at Evercore. It's my pleasure to host this next discussion with Summit Therapeutics. So we have Dave and Allen on stage now. We might have Bob and Maky jumping in here in the midst of this. And so in case that happens, don't be surprised. We fortunately have a little bit more time for this discussion. I'm sure you guys are excited about that. It's obviously been a very, very busy year for the company. So I mean, Dave, maybe I'll turn it over to you to kick things off by reviewing kind of the company's accomplishments thus far in 2025 and kind of act as a level se
Show less
Read more
Impact Snapshot
Event Time:
SMMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SMMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SMMT alerts
High impacting Summit Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
SMMT
News
- Summit: A Cautious Bet Backed By Anti-VEGF And Insider Buying [Seeking Alpha]Seeking Alpha
- Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- Summit Therapeutics Inc. (SMMT) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]Seeking Alpha
- Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducted by Akeso in ChinaBusiness Wire
- Summit Therapeutics to Present at Upcoming Investor ConferencesBusiness Wire
SMMT
Earnings
- 10/20/25 - Beat
SMMT
Sec Filings
- 11/7/25 - Form 8-K
- 10/29/25 - Form S-3ASR
- 10/23/25 - Form 4
- SMMT's page on the SEC website